1 BPC-157 (Body Protection Compound-157) Accelerating tendon and ligament healing in preclinical models Supporting gastrointestinal mucosal integrity and ulcer healing
2 Semaglutide (Ozempic) FDA-approved treatment for type 2 diabetes mellitus (as Ozempic/Rybelsus) FDA-approved chronic weight management in adults with obesity or overweight with comorbidities (as Wegovy)
3 Tirzepatide (Mounjaro) FDA-approved treatment for type 2 diabetes mellitus (as Mounjaro) FDA-approved for chronic weight management in adults with obesity or overweight with comorbidities (as Zepbound)
4 TB-500 (Thymosin Beta-4) Promoting wound healing and tissue repair in preclinical research Supporting tendon and ligament recovery in veterinary medicine
5 CJC-1295 (CJC-1295 DAC) Stimulating natural growth hormone secretion from the pituitary gland Anti-aging protocols aimed at optimizing growth hormone and IGF-1 levels
6 Ipamorelin (IPA) Selective stimulation of pituitary growth hormone release Anti-aging protocols for GH optimization with minimal side effects
7 PT-141 (Bremelanotide) FDA-approved treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women (as Vyleesi) Researched for male erectile dysfunction, including PDE5 inhibitor non-responders
8 GHK-Cu (Copper Peptide) Topical skin rejuvenation including reduction of fine lines and wrinkles Wound healing acceleration and post-procedure skin recovery
9 Melanotan II (MT-2) Stimulation of melanogenesis for skin tanning with reduced UV exposure Research into melanocortin system's role in pigmentation
10 AOD-9604 (Advanced Obesity Drug) Investigated for fat metabolism and body composition improvement Studied for stimulating lipolysis without growth-promoting effects
11 Sermorelin (Geref) Previously FDA-approved for growth hormone deficiency diagnosis and treatment in children Off-label use for age-related growth hormone decline in adults
12 Tesamorelin (Egrifta) FDA-approved for reduction of excess abdominal fat in HIV-associated lipodystrophy Stimulating natural growth hormone release through pituitary activation
13 GHRP-6 (Growth Hormone Releasing Peptide-6) Potent stimulation of growth hormone release from the pituitary gland Research tool for studying the GHS receptor and ghrelin signaling
14 GHRP-2 (Growth Hormone Releasing Peptide-2) Approved diagnostic agent for GH deficiency evaluation in Japan Potent stimulation of growth hormone release for research purposes
15 Hexarelin (Examorelin) Most potent acute GH release among GHRP-class peptides for research purposes Investigated for cardioprotective effects independent of GH release
16 Epithalon (Epitalon) Investigated for telomerase activation and telomere length maintenance Anti-aging research based on potential cellular rejuvenation
17 Selank (TP-7) Approved anxiolytic treatment in Russia for generalized anxiety Nootropic use for cognitive enhancement and mental clarity
18 Semax (MEHFPGP) Approved in Russia for stroke recovery and cerebral circulation disorders Cognitive enhancement and nootropic applications
19 LL-37 (Cathelicidin) Innate immune defense against bacterial, viral, and fungal pathogens Research into biofilm disruption for chronic infection management
20 KPV (Alpha-MSH Fragment) Research into inflammatory bowel disease (ulcerative colitis and Crohn's disease) Anti-inflammatory applications through NF-κB pathway inhibition
21 Thymalin (Thymus Extract Peptide) Immune system restoration in elderly and immunocompromised individuals Research into thymic function support during age-related involution
22 DSIP (Delta Sleep-Inducing Peptide) Promotion of restorative delta wave (slow-wave) sleep Research into chronic insomnia and sleep quality improvement
23 Kisspeptin-10 (KP-10) Research into fertility treatment and reproductive hormone stimulation Studied as a safer oocyte maturation trigger in IVF protocols
24 MGF (Mechano Growth Factor) Research into muscle satellite cell activation and proliferation Investigated for muscle repair and regeneration following injury
25 IGF-1 LR3 (Long R3 IGF-1) Research into muscle hypertrophy and protein synthesis Cell culture growth factor in laboratory research
26 Follistatin 344 (FST-344) Research into myostatin inhibition for muscle growth Investigated for muscular dystrophy treatment via gene therapy
27 Liraglutide (Victoza) FDA-approved treatment for type 2 diabetes (as Victoza) FDA-approved for weight management in adults and adolescents 12+ (as Saxenda)
28 Oxytocin (Pitocin) FDA-approved for labor induction and augmentation (as Pitocin) Prevention of postpartum hemorrhage
29 GLP-1 (Glucagon-Like Peptide-1) Biological template for GLP-1 receptor agonist drugs Natural postprandial blood glucose regulation
30 MOTS-c (Mitochondrial-Derived Peptide MOTS-c) Research into metabolic regulation and insulin sensitization Investigated as an exercise mimetic
31 Humanin (HN) Research into neuroprotection against Alzheimer's disease pathology Investigated for cardiovascular protection from ischemic injury
32 SS-31 (Elamipretide) Clinical trials for Barth syndrome (genetic mitochondrial cardiomyopathy) Investigated for heart failure and cardiac mitochondrial dysfunction
33 VIP (Vasoactive Intestinal Peptide) Investigated for Chronic Inflammatory Response Syndrome (CIRS) treatment Studied for pulmonary arterial hypertension
34 Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) Research into cognitive enhancement and synaptogenesis Investigated for neurodegenerative disease models including Alzheimer's
35 NAD+ (Nicotinamide Adenine Dinucleotide) Central role in cellular energy production and mitochondrial function DNA repair through PARP enzyme activation
36 Cerebrolysin (FPF 1070) Approved treatment for acute ischemic stroke in many countries Treatment of traumatic brain injury in clinical protocols
37 Snap-8 (Acetyl Octapeptide-3) Topical reduction of expression lines and wrinkles Cosmetic alternative to injectable neurotoxins for mild lines
38 Argireline (Acetyl Hexapeptide-3) Topical reduction of facial expression wrinkles Anti-aging skincare formulations as a gentle alternative to neurotoxin injections
39 Matrixyl (Palmitoyl Pentapeptide-4) Stimulation of collagen, elastin, and fibronectin production in the skin Reduction of fine lines and wrinkles through dermal matrix rebuilding
40 Collagen Peptides (Hydrolyzed Collagen) Oral supplementation for skin hydration, elasticity, and wrinkle reduction Joint health support and osteoarthritis symptom management
41 Glutathione (GSH) Master antioxidant defense protecting cells from oxidative damage Detoxification support through conjugation of harmful compounds
42 Retatrutide (LY3437943) Under clinical development for chronic weight management Investigated for type 2 diabetes treatment
43 Survodutide (BI 456906) Clinical development for chronic weight management Investigated for NASH/MASH treatment (liver fat reduction)
44 Orforglipron (LY3502970) Under clinical development for chronic weight management (oral formulation) Investigated for type 2 diabetes treatment as a daily oral medication
45 CagriSema (Cagrilintide/Semaglutide) Under clinical development for chronic weight management Investigated for type 2 diabetes treatment with enhanced weight loss
46 Pentadecapeptide (PDA) Tissue repair and regeneration research (primarily as BPC-157) Gastrointestinal protection and mucosal healing
47 ACE-031 (ActRIIB-Fc) Initially developed for Duchenne muscular dystrophy treatment Research into myostatin/activin pathway inhibition for muscle wasting
48 MK-677 (Ibutamoren) Oral stimulation of growth hormone and IGF-1 release Research into age-related GH decline and body composition
49 PE-22-28 (Spadin Analog) Research into novel antidepressant mechanisms via TREK-1 channel blockade Investigated for rapid-onset antidepressant effects in animal models
50 Thymosin Alpha-1 (Ta1) Approved treatment for hepatitis B in multiple countries Adjunctive treatment for hepatitis C with interferon in multiple countries